VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
63,479
AK1,562
AL4,914
AR3,110
AS44
AZ12,730
CA54,886
CO10,464
CT7,347
DC1,568
DE1,561
FL33,514
FM3
GA12,508
GU74
HI2,078
IA4,130
ID2,361
IL18,091
IN22,023
KS4,061
KY6,276
LA4,395
MA13,121
MD11,272
ME2,858
MH8
MI16,697
MN10,689
MO8,360
MP30
MS2,487
MT2,035
NC14,437
ND1,184
NE2,562
NH2,717
NJ16,033
NM3,532
NV3,784
NY30,921
OH17,029
OK5,673
OR7,479
PA21,111
PR1,959
QM2
RI1,833
SC5,601
SD1,087
TN8,048
TX31,896
UT3,791
VA13,180
VI48
VT1,592
WA13,026
WI9,856
WV2,120
WY754
XB5
XL1
XV2

ID: 1557159
Sex: F
Age: 23
State: AL

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue for 10 days after 1st dose; headache for 10 days after 1st dose; hot flashes for 10 days after 1st dose; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose). On 01-Feb-2021, FATIGUE (fatigue for 10 days after 1st dose), HEADACHE (headache for 10 days after 1st dose) and HOT FLUSH (hot flashes for 10 days after 1st dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication of the patient included Ibuprofen, Nyquil and Benadryl. No concomitant medications of the patient were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1557160
Sex: M
Age: 60
State: VA

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included GVHD and Stem cell transplant. Concomitant products included PREDNISONE, IBRUTINIB, AMOXICILLIN, ACYCLOVIR [ACICLOVIR], COLECALCIFEROL (VIT D [COLECALCIFEROL]) and LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported. This case was linked to MOD-2021-026779 (Patient Link).

Other Meds: PREDNISONE; IBRUTINIB; AMOXICILLIN; ACYCLOVIR [ACICLOVIR]; VIT D [COLECALCIFEROL]; LEVOXYL

Current Illness:

ID: 1557161
Sex: F
Age: 65
State: MS

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation; Felt a little ill; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt a little ill), VACCINATION SITE PAIN (Sore arm) and URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Felt a little ill) and VACCINATION SITE PAIN (Sore arm). On 23-Feb-2021, the patient experienced URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation). On 25-Feb-2021, MALAISE (Felt a little ill), VACCINATION SITE PAIN (Sore arm) and URTICARIA (bumps all over head, arms, legs, back which looked like mosquito bites with minor irritation) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557162
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 02/13/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: significant itching at the injection site; redness from elbow to below my shoulder; looked like a hematoma; soreness; redness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness) and VACCINATION SITE ERYTHEMA (redness at the injection site). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma). The patient was treated with BENZOCAINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (significant itching at the injection site), ERYTHEMA (redness from elbow to below my shoulder) and HAEMATOMA (looked like a hematoma) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1557163
Sex: F
Age: 20
State: MT

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain on left arm; petechiae; pyrexia; nausea; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea) and VOMITING (vomiting) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (Pain on left arm), PETECHIAE (petechiae), PYREXIA (pyrexia), NAUSEA (nausea), VOMITING (vomiting) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1557164
Sex: F
Age: 84
State: FL

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is still reddish and warm; arm is still reddish and warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm). At the time of the report, VACCINATION SITE ERYTHEMA (arm is still reddish and warm) and VACCINATION SITE WARMTH (arm is still reddish and warm) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557165
Sex: F
Age: 33
State: NY

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The patient's past medical history included Alcohol use (2-4 drinks a week) on 15-Dec-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from December 2020 to an unknown date for Pregnancy. On 25-Feb-2021 at 1:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 20-Nov-2020 and the estimated date of delivery was 27-Aug-2021. On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 25-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2020, Pregnancy test: positive (Positive) positive. On 22-Jan-2021, Ultrasound abdomen: normal (normal) NO ABNORMAL FINDINGS. On 12-Feb-2021, Ultrasound abdomen: normal (normal) NO ABNORMAL FINDINGS. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1557166
Sex: F
Age: 55
State: MN

Vax Date: 02/16/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.; armpit had a painful lump, like a swollen lymph node.; This spontaneous case was reported by a health care professional and describes the occurrence of LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.) and VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN B COMPLEX, FISH OIL and MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021 at 1:59 PM, the patient experienced LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.). On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.). The patient was treated with PARACETAMOL (TYLENOL) for Skin discomfort, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (armpit had a painful lump, like a swollen lymph node.) and VACCINATION SITE PAIN (skin is sensitive to touch, they feel sore all over, but more like a nerve endings kind of thing.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds: VITAMIN D [COLECALCIFEROL]; VITAMIN B COMPLEX; FISH OIL; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1557167
Sex: F
Age: 61
State: TX

Vax Date: 02/11/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: burning a little bit but nothing out of the ordinary; itching; little sore; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; it was a pretty big round red spot. it was itchy and hard, and red; This spontaneous case was reported by a patient and describes the occurrence of BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high and Asthma. Concomitant products included ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]) for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red). At the time of the report, BURNING SENSATION (burning a little bit but nothing out of the ordinary), PRURITUS (itching), PAIN IN EXTREMITY (little sore), VACCINATION SITE INDURATION (it was a pretty big round red spot. it was itchy and hard, and red), VACCINATION SITE PRURITUS (it was a pretty big round red spot. it was itchy and hard, and red) and VACCINATION SITE ERYTHEMA (it was a pretty big round red spot. it was itchy and hard, and red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.

Other Meds: VITAMIN D [ERGOCALCIFEROL]

Current Illness: Asthma; Blood pressure high

ID: 1557168
Sex: F
Age: 75
State: NY

Vax Date: 02/21/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu-like symptoms; slept for an entire day; Bad Aches; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No medical history was reported. On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), HYPERSOMNIA (slept for an entire day), PAIN (Bad Aches) and VOMITING (throwing up) outcome was unknown. No concomitant medications were provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557169
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm was heavy; Her pain level was 3; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical history provided. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3). At the time of the report, LIMB DISCOMFORT (Arm was heavy) and PAIN IN EXTREMITY (Her pain level was 3) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient did not do any treatment. No concomitant medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Live follow up received on 21-Apr-2021: Patient said she was doing fine but not sure about getting 2nd dose. She did not want further follow up.

Other Meds:

Current Illness:

ID: 1557170
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown. Concomitant medication and treatment information were not reported. Action taken with mRNA-1273 in response to the event was Not Applicable

Other Meds:

Current Illness:

ID: 1557171
Sex: F
Age: 62
State: NC

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: winded fast; panic attacks; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The patient's past medical history included Bronchitis (started on antibiotics) and COVID-19 (11 days quarantined.) on 15-Jan-2021. Concurrent medical conditions included Fibromyalgia, Anxiety, Obsessive-compulsive disorder, Stomach discomfort and Hypertension. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue). The patient was treated with COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (winded fast), PANIC ATTACK (panic attacks), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 antibody test: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included medications for blood pressure, OCD and Anxiety, Stomach issues. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: No new information.

Other Meds:

Current Illness: Anxiety; Fibromyalgia; Hypertension; Obsessive-compulsive disorder; Stomach discomfort

ID: 1557172
Sex: F
Age:
State: NY

Vax Date: 02/12/2021
Onset Date: 02/21/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sleepiness; weakness; malaise; brain fog; inability to rise from her bed the morning; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog) and DYSSTASIA (inability to rise from her bed the morning) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Heart valve replacement (significant for valve replacement) in May 2020 and Pacemaker insertion (cardiac) in May 2020. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue). On 24-Feb-2021, SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Both medical history were added.

Other Meds:

Current Illness:

ID: 1557173
Sex: F
Age: 69
State: TX

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dry mouth at night; cramping in her stomach; IBS maybe actin up; pain at the injection site; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea). At the time of the report, DRY MOUTH (Dry mouth at night), ABDOMINAL PAIN UPPER (cramping in her stomach), IRRITABLE BOWEL SYNDROME (IBS maybe actin up), VACCINATION SITE PAIN (pain at the injection site) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557174
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; Runny Nose; not sure if 0.5mL. Had both injections; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (sore arm), RHINORRHOEA (Runny Nose) and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (sore arm), RHINORRHOEA (Runny Nose) and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections). At the time of the report, INJECTION SITE PAIN (sore arm) and RHINORRHOEA (Runny Nose) outcome was unknown and INCORRECT DOSE ADMINISTERED (not sure if 0.5mL. Had both injections) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557175
Sex: F
Age: 49
State: MD

Vax Date: 02/10/2021
Onset Date: 02/26/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bellafill facial filler was "hard as a rock"; This spontaneous case was reported by a consumer and describes the occurrence of INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock") in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included Dermal filler injection (Patient states the filler was put in 5 years ago) since April 2016. Concurrent medical conditions included Food allergy (Patient is allergic to wheat and oats) and Shellfish allergy (Patient is allergic to Shellfish allergy). On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock"). At the time of the report, INSTILLATION SITE INDURATION (Bellafill facial filler was "hard as a rock") outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness: Dermal filler injection (Patient states the filler was put in 5 years ago); Food allergy (Patient is allergic to wheat and oats); Shellfish allergy (Patient is allergic to Shellfish allergy)

ID: 1557176
Sex: F
Age: 23
State: AL

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Describes the rash as hives; Woke up with rash on the lower half of her face and neck; Fever of 102F after 2nd dose; Severe reaction after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION COMPLICATION (Severe reaction after 2nd dose). On 23-Feb-2021, the patient experienced PYREXIA (Fever of 102F after 2nd dose). On 25-Feb-2021, the patient experienced URTICARIA (Describes the rash as hives) and RASH (Woke up with rash on the lower half of her face and neck). At the time of the report, URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 102 (Inconclusive) 102 F. No concomitant and treatment medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable. This case was linked to MOD-2021-026651 (Patient Link).

Other Meds:

Current Illness:

ID: 1557177
Sex: F
Age: 92
State: IN

Vax Date: 02/25/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: urinary track infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary track infection) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was reported. On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced URINARY TRACT INFECTION (urinary track infection). The patient was treated with CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) ongoing from 24-Feb-2021 for UTI, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (urinary track infection) outcome was unknown. Concomitant product use was not reported. Treatment product use was not reported. Follow up email received on 01Jul2021 from the reporter states that there was no remarkable connection of urinary tract infection to Moderna vaccine Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Correspondence follow up email attached: casuality updated

Other Meds:

Current Illness:

ID: 1557178
Sex: F
Age: 79
State: FL

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Upper arm soreness; Muscle soreness; Pain when lifting arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included METOPROLOL, LOSARTAN, ATORVASTATIN, VITAMIN supplements, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), HCTZ, RALOXIFENE and IBANDRONATE SODIUM (IBANDRONATE) for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm). At the time of the report, AXILLARY PAIN (Upper arm soreness), MYALGIA (Muscle soreness) and MOVEMENT DISORDER (Pain when lifting arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: METOPROLOL; LOSARTAN; ATORVASTATIN; VITAMIN supplements; ASPIRIN (E.C.); HCTZ; RALOXIFENE; IBANDRONATE

Current Illness:

ID: 1557179
Sex: F
Age:
State: FL

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: "electrical shot" all over body; This spontaneous case was reported by a consumer and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. 24Feb2021 Within 30 minutes after vaccination, Patient felt like an "electric shot" all over body. Action taken with mRNA-1273 in response to the events was not Applicable. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1557180
Sex: F
Age: 83
State: CA

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: One leg has little red spots on it, like a rash; Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together). At the time of the report, RASH MACULAR (One leg has little red spots on it, like a rash) and RASH (Rash is all over her body, arms and ankles, face,rash and it's still ongoing,rash that runs together) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medication was reported. Patient gave consent to safety for Follow-up.

Other Meds:

Current Illness:

ID: 1557181
Sex: F
Age: 80
State: MD

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sick to the stomach; Diarrhea; didn't feel like eating anything; Sore Throat; Swollen; Runny nose; hot and cold; Sore; tired; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat) and SWELLING (Swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in April 2020 and Pneumonia in April 2021. Concurrent medical conditions included Gout, Urine abnormality, Hypertension, Neuralgia, Kidney disorder, Allergy and Hypercholesteraemia. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, ALLOPURINOL for Gout, FISH OIL for Hypercholesterolaemia, ATENOLOL for Hypertension, CALCITRIOL for Kidney disorder, SERTRALINE for Neuralgia, BUMETANIDE for Urine abnormality, SALBUTAMOL (ALBUTEROL HFA) and VITAMIN D NOS for an unknown indication. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (sick to the stomach), DIARRHOEA (Diarrhea), DECREASED APPETITE (didn't feel like eating anything), OROPHARYNGEAL PAIN (Sore Throat), SWELLING (Swollen), RHINORRHOEA (Runny nose), FEELING OF BODY TEMPERATURE CHANGE (hot and cold), PAIN (Sore), FATIGUE (tired), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 antibody test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-106316 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter details updated, concomitant and medical history added, new event diarrhea added AND second dose events new case created and linked

Other Meds: ALLOPURINOL; BUMETANIDE; ATENOLOL; SERTRALINE; CALCITRIOL; ALBUTEROL HFA; ZYRTEC ALLERGY; FISH OIL; VITAMIN D NOS

Current Illness: Gout; Hypercholesteraemia; Hypertension; Kidney disorder; Neuralgia; Urine abnormality

ID: 1557182
Sex: F
Age:
State: PA

Vax Date: 02/04/2021
Onset Date: 02/01/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chattering teeth/Chills; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (chattering teeth/Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced CHILLS (chattering teeth/Chills). At the time of the report, CHILLS (chattering teeth/Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1557183
Sex: F
Age: 65
State:

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mouth turned to the left side; Body aches; Abdominal pain; Trembling really strong; Extreme sweat; Pain in the left leg; Headache; Fever of 101?F; Chills; This spontaneous case was reported by a nurse and describes the occurrence of DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong) and HYPERHIDROSIS (Extreme sweat) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Asthma and Hypertension. Concurrent medical conditions included Anxiety, Blood pressure high, Allergic reaction to food, Allergic reaction to drug and Penicillin allergy. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DYSKINESIA (Mouth turned to the left side), PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PAIN IN EXTREMITY (Pain in the left leg), HEADACHE (Headache), PYREXIA (Fever of 101?F) and CHILLS (Chills). On 25-Feb-2021, PAIN (Body aches), ABDOMINAL PAIN (Abdominal pain), TREMOR (Trembling really strong), HYPERHIDROSIS (Extreme sweat), PYREXIA (Fever of 101?F) and CHILLS (Chills) had resolved. At the time of the report, DYSKINESIA (Mouth turned to the left side), PAIN IN EXTREMITY (Pain in the left leg) and HEADACHE (Headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 101 (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It is reported that patient is currently consuming High blood pressure and Anxiety medication. This case was linked to MOD-2021-026852 (Patient Link).

Other Meds:

Current Illness: Allergic reaction to drug; Allergic reaction to food; Anxiety; Blood pressure high; Penicillin allergy

ID: 1557184
Sex: F
Age: 82
State: IL

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness; weakness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (dizziness), ASTHENIA (weakness) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557185
Sex: F
Age: 75
State: MO

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Leaked from patient's arm; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE DISCHARGE (Leaked from patient's arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Leaked from patient's arm). At the time of the report, VACCINATION SITE DISCHARGE (Leaked from patient's arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported No treatment was specified

Other Meds:

Current Illness:

ID: 1557186
Sex: F
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ADVERSE REACTION (Adverse reaction). At the time of the report, ADVERSE REACTION (Adverse reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557187
Sex: F
Age: 84
State: WI

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hurt quite a bit; Upper arm was swollen and red; Upper arm was swollen and red; Got kind of lumpy and hurt quite a bit for about 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concomitant products included BISOPROLOL, VERAPAMIL, CANDESARTAN, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and TIOTROPIUM BROMIDE (SPIRIVA) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Hurt quite a bit), PERIPHERAL SWELLING (Upper arm was swollen and red), ERYTHEMA (Upper arm was swollen and red) and SWELLING (Got kind of lumpy and hurt quite a bit for about 4 days) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Patient took second dose on 24-FEB-2021. This case was linked to MOD-2021-040508 (Patient Link).

Other Meds: BISOPROLOL; VERAPAMIL; CANDESARTAN; SYMBICORT; SPIRIVA

Current Illness:

ID: 1557188
Sex: M
Age: 78
State: AZ

Vax Date: 02/19/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M2014) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, INJECTION SITE PRURITUS (Itchiness) and INJECTION SITE PAIN (Pain at injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1557189
Sex: F
Age: 69
State: VA

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in the collar bone and near the breast; soreness; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX), SERTRALINE, ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO), CETIRIZINE, SIMVASTATIN and PANTOPRAZOLE for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BONE PAIN (Pain in the collar bone and near the breast) and BREAST PAIN (soreness) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Second dosing regimen added. Action taken updated from unknown to not applicable. Preferred term updated for pain. Outcome updated.

Other Meds: VALTREX; SERTRALINE; PREMPRO; CETIRIZINE; SIMVASTATIN; PANTOPRAZOLE

Current Illness:

ID: 1557190
Sex: F
Age: 33
State: CA

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: also left chest pain; red rush on the left side of her chest in the back and front; itchy rush on the left side of her chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included INSULIN and METFORMIN for an unknown indication. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest). On 31-Jan-2021, CHEST PAIN (also left chest pain), RASH ERYTHEMATOUS (red rush on the left side of her chest in the back and front) and RASH PRURITIC (itchy rush on the left side of her chest) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: INSULIN; METFORMIN

Current Illness:

ID: 1557191
Sex: M
Age:
State: FL

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling of the throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling of the throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swelling of the throat). At the time of the report, PHARYNGEAL SWELLING (Swelling of the throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided.

Other Meds:

Current Illness:

ID: 1557192
Sex: F
Age: 64
State: TX

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fever of 99.6F; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Hypertension, MAGNESIUM, VITAMIN C [ASCORBIC ACID], ZINC and AMYLASE, ASCORBIC ACID, CELLULASE, FOLIC ACID, LIPASE, PROTEASE NOS (JUICE PLUS) for an unknown indication. On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Pyrexia: 99.6 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided. This case was linked to MOD-2021-029583 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Hypertension, MAGNESIUM, VITAMIN C [ASCORBIC ACID], ZINC and AMYLASE, ASCORBIC ACID, CELLULASE, FOLIC ACID, LIPASE, PROTEASE NOS (JUICE PLUS) for an unknown indication. On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, CHILLS (chills), PYREXIA (fever of 99.6F) and VACCINATION SITE PAIN (arm soreness) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Pyrexia: 99.6 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided. This case was linked to MOD-2021-029583 (Patient Link).

Other Meds: BYSTOLIC; MAGNESIUM; VITAMIN C [ASCORBIC ACID]; ZINC; JUICE PLUS

Current Illness: Hypertension

ID: 1557193
Sex: F
Age: 43
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain at the injection site; fever; chills; muscle aches; joint paint; Changes in the way some things smell; Loss of appetite; A spontaneous report was received from a consumer a 43-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever/Pyrexia, pain at the injection site/Injection site pain, chills, muscle aches/Myalgia, joint paint/Arthralgia, Changes in the way some things smell/Parosmia, Loss of appetite/Decreased appetite. The patient's medical history was not provided by the reporter. Concomitant medications was not provided by the reporter. On 1st Feb 2021 the patient received their first of two planned doses of mRNA-1273 intramuscularly in unknown location for prophylaxis of COVID-19 infection. on 1st Feb prior to receiving mRNA-1273, patient experienced pain at the injection site, fever, chills, muscle aches, joint pains, loss of appetite and changes in the way some things smell. Treatment information is not provided. Action taken with mRNA-1273 in response to the events is not applicable. The outcome of the event fever, pain at the injection site, chills, muscle aches, joint paint, Changes in the way some things smell, Loss of appetite was not reported.

Other Meds:

Current Illness:

ID: 1557194
Sex: F
Age: 59
State: CA

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; SWEATY; weak; Fatigue; thirsty; Left shoulder is weak; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue) and THIRST (thirsty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak) outcome was unknown. Not Provided No relevant Concomitant medications were reported. No Treatment information for the event was provided. This case was linked to MOD-2021-026636 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue) and THIRST (thirsty) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), HYPERHIDROSIS (SWEATY), ASTHENIA (weak), FATIGUE (Fatigue), THIRST (thirsty) and MUSCULAR WEAKNESS (Left shoulder is weak) outcome was unknown. Not Provided No relevant Concomitant medications were reported. No Treatment information for the event was provided.

Other Meds:

Current Illness:

ID: 1557195
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She was having some symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (She was having some symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (She was having some symptoms). At the time of the report, ADVERSE EVENT (She was having some symptoms) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication were provided by the reporter. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (She was having some symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (She was having some symptoms). At the time of the report, ADVERSE EVENT (She was having some symptoms) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication were provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1557196
Sex: M
Age: 73
State: OR

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle soreness worse this morning; developed a fever (99.8 F); "really tired" & "heavy duty fatigue"; took a nap; sweating; muscle soreness in back; muscle soreness in legs and arms; muscle soreness in neck; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms) and NECK PAIN (muscle soreness in neck) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 02-Nov-2020 and Influenza since an unknown date. Concurrent medical conditions included Ulcerative colitis, Benign prostatic hyperplasia and Hypertension. Concomitant products included ALFUZOSIN for Benign prostatic hyperplasia, HCTZ for Hypertension, MESALAMINE for Ulcerative colitis, VITAMIN D NOS for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms), NECK PAIN (muscle soreness in neck), PYREXIA (developed a fever (99.8 F)) and FATIGUE ("really tired" & "heavy duty fatigue"). On 25-Feb-2021, the patient experienced MYALGIA (muscle soreness worse this morning). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 25-Feb-2021, PYREXIA (developed a fever (99.8 F)) had resolved. At the time of the report, SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms), NECK PAIN (muscle soreness in neck), MYALGIA (muscle soreness worse this morning) and FATIGUE ("really tired" & "heavy duty fatigue") outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Pyrexia: 99.8 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication includes Aspirin for unknown indication. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms) and NECK PAIN (muscle soreness in neck) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 02-Nov-2020 and Influenza since an unknown date. Concurrent medical conditions included Ulcerative colitis, Benign prostatic hyperplasia and Hypertension. Concomitant products included ALFUZOSIN for Benign prostatic hyperplasia, HCTZ for Hypertension, MESALAMINE for Ulcerative colitis, VITAMIN D NOS for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms), NECK PAIN (muscle soreness in neck), PYREXIA (developed a fever (99.8 F)) and FATIGUE ("really tired" & "heavy duty fatigue"). On 25-Feb-2021, the patient experienced MYALGIA (muscle soreness worse this morning). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 25-Feb-2021, PYREXIA (developed a fever (99.8 F)) had resolved. At the time of the report, SOMNOLENCE (took a nap), HYPERHIDROSIS (sweating), BACK PAIN (muscle soreness in back), PAIN IN EXTREMITY (muscle soreness in legs and arms), NECK PAIN (muscle soreness in neck), MYALGIA (muscle soreness worse this morning) and FATIGUE ("really tired" & "heavy duty fatigue") outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Pyrexia: 99.8 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication includes Aspirin for unknown indication.

Other Meds: MESALAMINE; ALFUZOSIN; HCTZ; VITAMIN D NOS

Current Illness: Benign prostatic hyperplasia; Hypertension; Influenza; Ulcerative colitis

ID: 1557197
Sex: F
Age:
State: MD

Vax Date: 02/10/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: It is swollen up; inflamation; arm started hurting; My entire arm hurts, from my fingers to my shoulder; I am in tremendous pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation), PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder), PAIN (I am in tremendous pain) and PAIN IN EXTREMITY (arm started hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder) and PAIN (I am in tremendous pain). On an unknown date, the patient experienced PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation) and PAIN IN EXTREMITY (arm started hurting). At the time of the report, PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation), PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder), PAIN (I am in tremendous pain) and PAIN IN EXTREMITY (arm started hurting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product details provided. Patient went to the hospital for the reported events. No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation), PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder), PAIN (I am in tremendous pain) and PAIN IN EXTREMITY (arm started hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder) and PAIN (I am in tremendous pain). On an unknown date, the patient experienced PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation) and PAIN IN EXTREMITY (arm started hurting). At the time of the report, PERIPHERAL SWELLING (It is swollen up), INFLAMMATION (inflamation), PAIN IN EXTREMITY (My entire arm hurts, from my fingers to my shoulder), PAIN (I am in tremendous pain) and PAIN IN EXTREMITY (arm started hurting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product details provided. Patient went to the hospital for the reported events. No Treatment information for the event was provided.

Other Meds:

Current Illness:

ID: 1557198
Sex: F
Age: 72
State: FL

Vax Date: 02/17/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feels like have fever in it; Itch; 4 in x 4 in Red; Rash; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Pollen allergy and Drug allergy (Amoxicillin allergy.). On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash). The patient was treated with HYDROCORTISONE at a dose of Cream. At the time of the report, FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concurrent medical conditions included Pollen allergy and Drug allergy (Amoxicillin allergy.). On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash). The patient was treated with HYDROCORTISONE at a dose of Cream. At the time of the report, FEELING HOT (Feels like have fever in it), PRURITUS (Itch), ERYTHEMA (4 in x 4 in Red) and RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness: Drug allergy (Amoxicillin allergy.); Pollen allergy

ID: 1557199
Sex: M
Age: 53
State: KS

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Aches in my body; Joint pain; Tiredness; A low-grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021 at 7:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant Concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021 at 7:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Aches in my body), ARTHRALGIA (Joint pain), FATIGUE (Tiredness), PYREXIA (A low-grade fever) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant Concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1557200
Sex: M
Age: 76
State: FL

Vax Date: 01/27/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: site of injection started itching and developed red mark (5 inches long); site of injection started itching and developed red mark (5 inches long); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (site of injection started itching and developed red mark (5 inches long)) and VACCINATION SITE ERYTHEMA (site of injection started itching and developed red mark (5 inches long)) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. No relevant concomitant medications reported. No relevant medical history was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE PRURITUS (site of injection started itching and developed red mark (5 inches long)). 24-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (site of injection started itching and developed red mark (5 inches long)). At the time of the report, INJECTION SITE PRURITUS (site of injection started itching and developed red mark (5 inches long)) and VACCINATION SITE ERYTHEMA (site of injection started itching and developed red mark (5 inches long)) had not resolved. Treatment medicines include Cortozone-10 cream

Other Meds:

Current Illness:

ID: 1557201
Sex: F
Age: 62
State: NC

Vax Date: 12/30/2020
Onset Date: 01/27/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen arm; Fever; Chills; Swollen lymph nodes (neck and back of head); Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PYREXIA (Fever), CHILLS (Chills), LYMPHADENOPATHY (Swollen lymph nodes (neck and back of head)) and MYALGIA (Body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PYREXIA (Fever), CHILLS (Chills), LYMPHADENOPATHY (Swollen lymph nodes (neck and back of head)) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Jan-2021, PERIPHERAL SWELLING (Swollen arm), PYREXIA (Fever), CHILLS (Chills) and LYMPHADENOPATHY (Swollen lymph nodes (neck and back of head)) had resolved. On 28-Jan-2021, MYALGIA (Body aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 100.5 (Inconclusive) 100.5. No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1557202
Sex: F
Age: 33
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Received the two doses of the vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Received the two doses of the vaccine while pregnant) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 043L20A) for COVID-19 vaccination. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021 at 9:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 09-Sep-2021. On 15-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Received the two doses of the vaccine while pregnant). On 25-Feb-2021, EXPOSURE DURING PREGNANCY (Received the two doses of the vaccine while pregnant) had resolved. Not Provided; Reporter's Comments: This case concerns a 33 year-old, female patient, who is pregnant and experienced an event of exposure during pregnancy after receiving her first and then the second dose of mRNA-1273 vaccine on the 11th week of pregnancy. No adverse events were reported.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1557203
Sex: F
Age: 79
State: SC

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Pain in her shoulder). At the time of the report, ARTHRALGIA (Pain in her shoulder) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 09-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Pain in her shoulder). At the time of the report, ARTHRALGIA (Pain in her shoulder) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant Concomitant medications were reported. No Treatment information for the event was provided.

Other Meds:

Current Illness:

ID: 1557204
Sex: F
Age: 37
State: NJ

Vax Date: 01/25/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bloating discomfort that comes and goes in her stomach and even in her back; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (bloating discomfort that comes and goes in her stomach and even in her back) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No relevant concomitant medications reported. No relevant medical history was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced ABDOMINAL DISTENSION (bloating discomfort that comes and goes in her stomach and even in her back). At the time of the report, ABDOMINAL DISTENSION (bloating discomfort that comes and goes in her stomach and even in her back) outcome was unknown. Treatment medicine include antacid.

Other Meds:

Current Illness:

ID: 1557205
Sex: F
Age:
State: IL

Vax Date: 02/10/2021
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later; it is very itchy and red; it is very itchy and red; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. Concomitant products included ATENOLOL, LOSARTAN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6), ASCORBIC ACID (VITAMIN C [ASCORBIC ACID]), ROSUVASTATIN, FAMOTIDINE and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reported concomitant medication including Nebulizer treatment. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021. This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. Concomitant products included ATENOLOL, LOSARTAN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6), ASCORBIC ACID (VITAMIN C [ASCORBIC ACID]), ROSUVASTATIN, FAMOTIDINE and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Pt got 1st dose of vaccine and developed skin rash on injection site approximately 2 weeks later), VACCINATION SITE PRURITUS (it is very itchy and red) and VACCINATION SITE ERYTHEMA (it is very itchy and red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reported concomitant medication including Nebulizer treatment.

Other Meds: ATENOLOL; LOSARTAN; ASPIRIN (E.C.); CALCIUM; MULTIVITAMIN 6; VITAMIN C [ASCORBIC ACID]; ROSUVASTATIN; FAMOTIDINE; SYMBICORT

Current Illness:

ID: 1557206
Sex: F
Age:
State: MN

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever 101; Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (fever 101) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 virus test positive in October 2020 and Fever (Fever ran for 16 days) in October 2020. Concomitant products included APIXABAN (ELIQUIS), BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS RHAMNOSUS (PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]), ROSUVASTATIN CALCIUM (CRESTOR) and CALCIUM CARBONATE (OSCAL [CALCIUM CARBONATE]) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (Chills). On 26-Feb-2021, the patient experienced PYREXIA (fever 101). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, CHILLS (Chills) and PYREXIA (fever 101) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Pyrexia: 101. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 27-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (fever 101) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 virus test positive in October 2020 and Fever (Fever ran for 16 days) in October 2020. Concomitant products included APIXABAN (ELIQUIS), BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS RHAMNOSUS (PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]), ROSUVASTATIN CALCIUM (CRESTOR) and CALCIUM CARBONATE (OSCAL [CALCIUM CARBONATE]) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (Chills). On 26-Feb-2021, the patient experienced PYREXIA (fever 101). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, CHILLS (Chills) and PYREXIA (fever 101) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Pyrexia: 101. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: ELIQUIS; PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]; CRESTOR; OSCAL [CALCIUM CARBONATE]

Current Illness:

ID: 1557207
Sex: F
Age: 66
State: TX

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears; both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears; both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears; both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date, Cholesterol since an unknown date, Depression since an unknown date and Anxiety since an unknown date. Concomitant products included VITAMIN D NOS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears). On an unknown date, the patient experienced LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears). At the time of the report, PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product were provided by the reporter that are Medication for high blood pressure, Medication for high cholesterol, Medication for depression, and Medication for anxiety No treatment medication were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 27-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date, Cholesterol since an unknown date, Depression since an unknown date and Anxiety since an unknown date. Concomitant products included VITAMIN D NOS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears). On an unknown date, the patient experienced LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears). At the time of the report, PAIN IN EXTREMITY (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), LIMB DISCOMFORT (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears), SENSITIVE SKIN (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) and LACRIMATION INCREASED (both her arms are in a lot of pain and very sensitive to the point she can't grab anything and is almost in tears) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product were provided by the reporter that are Medication for high blood pressure, Medication for high cholesterol, Medication for depression, and Medication for anxiety No treatment medication were reported.

Other Meds: VITAMIN D NOS; BABY ASPIRIN

Current Illness: Anxiety; Cholesterol; Depression; Hypertension

ID: 1557208
Sex: F
Age:
State: CA

Vax Date: 01/31/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: whole day migraine; right arm was in pain; dizzy; weak and overly tired; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (whole day migraine), PAIN IN EXTREMITY (right arm was in pain), DIZZINESS (dizzy) and FATIGUE (weak and overly tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (whole day migraine), PAIN IN EXTREMITY (right arm was in pain), DIZZINESS (dizzy) and FATIGUE (weak and overly tired). At the time of the report, MIGRAINE (whole day migraine), PAIN IN EXTREMITY (right arm was in pain), DIZZINESS (dizzy) and FATIGUE (weak and overly tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. concomitant medicines was not reported by reporter Treatment medication: Pain killers for the pain on her arm For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 559,999

Page last modified: 03 October 2021 5:28pm